Cite
HARVARD Citation
Sebio, A. et al. (n.d.). 2010 A genetic variant in RASSF1A, a key regulator of HIPPO pathway, predicts survival in two independent cohorts of mCRC patients treated with cetuximab-based chemotherapy. European journal of cancer. pp. S331-. [Online].